Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novo Nordisk
Novo Nordisk
Novo Nordisk, Evotec partner in metabolic disease drug discovery pact
BioPharma Dive
Tue, 09/26/23 - 09:51 pm
Novo Nordisk
Evotec
drug discovery
LAB eN²
metabolic diseases
Novo Nordisk and Valo to research cardiometabolic treatments
Reuters
Mon, 09/25/23 - 10:16 am
Novo Nordisk
Valo Health
R&D
artificial intelligence
cardiometabolic diseases
Obesity Drug Market Set to Hit $100 Billion by 2035, BMO Says
Yahoo/Bloomberg
Sun, 09/24/23 - 08:56 pm
Novo Nordisk
Ozempic
Wegovy
obesity
weight loss
Why a hidden message in Ozempic’s logo represents a big shift in drug branding
Fast Company
Fri, 09/22/23 - 12:03 pm
Novo Nordisk
Ozempic
logo
branding
diabetes
weight loss
Novo Nordisk Foundation to establish €127 million cell therapy plant
Biopharma Reporter
Thu, 09/21/23 - 06:39 pm
Novo Nordisk
cell therapy
Denmark
Why Novo Nordisk Stock Edged Higher Today
Motley Fool
Wed, 09/20/23 - 11:06 pm
Novo Nordisk
Ypsomed
drug manufacturing
Inside the FDA's Form 483 findings at Novo Nordisk's North Carolina semaglutide plant
Fierce Pharma
Tue, 09/19/23 - 10:19 pm
Novo Nordisk
FDA
drug manufacturing
semaglutide
North Carolina
Novo Nordisk taps Aspen to help produce insulin for Africa
Fierce Pharma
Tue, 09/19/23 - 10:49 am
Novo Nordisk
diabetes
Africa
insulin
Aspen Pharmacare
drug manufacturing
Novo Nordisk Dives After FDA Reportedly Finds 'Objectionable' Conditions At A Key Wegovy Plant
Investors Business Daily
Mon, 09/18/23 - 07:58 pm
Novo Nordisk
drug manufacturing
FDA
Wegovy
Novo Nordisk hires private U.S. firm to handle some Wegovy pen assembly
Reuters
Mon, 09/18/23 - 12:35 pm
Novo Nordisk
Wegovy
PCI Pharma Services
drug manufacturing
Ozempic-Maker Invests in Renewables
Daily Upside
Thu, 09/14/23 - 11:06 pm
Novo Nordisk
sustainability
renewable energy
Novo, Lilly set to dominate $71B GLP-1 drug market by 2032: J.P. Morgan
Fierce Pharma
Mon, 09/11/23 - 12:26 pm
Novo Nordisk
Eli Lilly
GLP-1 agonist
obesity
After treatment with semaglutide, people with newly diagnosed type 1 diabetes needed little or no insulin
Medical News Today
Sun, 09/10/23 - 08:03 pm
Novo Nordisk
Ozempic
semaglutide
type 1 diabetes
Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts
Fierce Pharma
Fri, 09/8/23 - 10:29 am
M&A
patent cliffs
Merck
JNJ
Pfizer
GSK
Novartis
Eli Lilly
Novo Nordisk
Novo Nordisk Is Already Working on Ozempic 2.0
Motley Fool
Thu, 09/7/23 - 10:12 am
Novo Nordisk
diabetes
obesity
weight loss
Ozempic
Wegovy
The 10 highest value R&D projects in biopharma
Fierce Biotech
Wed, 09/6/23 - 10:17 am
R&D
biotech
Merck
sotatercept
Daiichi Sankyo
AstraZeneca
Dato-DXd
Novo Nordisk
CagriSema
Eli Lilly
donanemab
Karuna Therapeutics
Zai Lab
KarXT
Moderna Therapeutics
mRNA-1647
Novartis
iptacopan
Madrigal Pharmaceuticals
resmetirom
Cytokinetics
aficamten
Roche
Chugai
tiragolumab
Weight-loss drug maker Novo Nordisk becomes Europe’s most valuable company
FT.com
Tue, 09/5/23 - 11:38 am
Novo Nordisk
Wegovy
Europe
weight loss
Novo Nordisk launches Wegovy for obese patients in UK
Pharmaceutical Business Review
Tue, 09/5/23 - 11:25 am
Novo Nordisk
UK
Wegovy
obesity
Signal: Novo Nordisk market cap higher than Danish GDP due to obesity drugs
Clinical Trials Arena
Fri, 09/1/23 - 12:18 pm
Novo Nordisk
Wegovy
Ozempic
Denmark
Wegovy costs $1.1m to prevent one heart attack, stroke, or cardiovascular death
Airfinity
Thu, 08/31/23 - 11:52 am
Novo Nordisk
Wegovy
Ozempic
cardiovascular disease
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »